Navigation Links
Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
Date:12/7/2009

the Oralair(R) program as a whole, which remain extremely consistent. The development program, which focuses on the benefit to patients and fits squarely with current cost-containment trends, confirms the relevance of Stallergenes' strategic choices.

Our 2009 clinical news flow has been very dense and is not over yet. There are still more results to come and more analyses to be conducted. We will be delighted to present all these findings at an R&D day to be held at the start of 2010." says Albert Saporta, Chairman and CEO of Stallergenes.

ABOUT ORALAIR(R)

The Oralair(R) clinical development program has demonstrated the short-term efficacy of the product at an appropriate dose of 300 IR during the first season, through two clinical studies in adults and children (VO34.04 and VO52.06).

Through a pharmacodynamics study (V056.07), Stallergenes demonstrated that its immunotherapy tablet had an effect on symptoms from the very first month of treatment, without the use of rescue medication and irrespective of variable patient exposure to pollen.

The Oralair(R) development program, which has so far included over 1,800 patients, makes the level of clinical evidence for this treatment indisputable. This program, which was initiated in 2003 and is fully in line with EMEA guidelines issued in 2008, will help immunotherapy tablets achieve the same level of recognition as conventional pharmaceuticals.

From the outset, the Oralair(R) clinical development program has addressed the key issues involved in grass pollen immunotherapy:

    - It answers the unmet needs of patients suffering from severe
      rhino-conjunctivitis caused by grass pollen, inadequately controlled
      using symptomatic treatments,

    - It favors compliance and cost-containment, through its pre-
      and coseasonal protocol (the treatment is taken for four months prior
      to the pollen seaso
'/>"/>
SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
2. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
3. Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amiras Lead DP2 Antagonist, AM211
4. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
5. ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
6. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
7. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
8. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
9. Zydena is Efficacious in Once Daily Dosing for Erectile Dysfunction/Positive BPH Results
10. Epiphany Announces Positive Results from Its Phase 2b Trial in Shingles.
11. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Now available for sale, The Armor1 Ankle Roll ... ankle sprains by cushioning the ankle from an inversion ... the outside of any shoe type and allows the ... offering protection against sprains. With customers in physical therapy, ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
(Date:1/22/2015)... 22, 2015  ViewRay™, a privately held medical device company, ... distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: ... the treatment of cancer in Japan ... world,s first and only MRI-guided radiation therapy system that ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... , , ... U.S. Food and Drug Administration today warned consumers and health care professionals about a ... or long-term use of a class of medications called proton pump inhibitors. The product ... , , ...
... ALLENTOWN, Pa. and CAMPBELL, Calif. ... physicians and patients sophisticated risk characterization and personalized ... performing a battery of advanced tests, offering an ... MD, Hunter,s Medical Director stated:  "With appropriate risk ...
Cached Medicine Technology:FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors 2FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors 3Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program. 2
(Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... 22, 2015 Joan Lunden, award-winning American ... at the upcoming 32nd Annual Miami Breast Cancer ... Education Resource®, LLC (PER®) , shares that “a fast-growing, ... undetected if she had not followed up her clean ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... Healthcare Realty Trust Incorporated (NYSE: HR ) ... 2009. Funds from operations ("FFO") per diluted common share ... compared with $0.39 for the three months ended March 31, ... share for the three months ended March 31, 2009, before ...
... (NYSE: AOC ) Chairman, Lester B. Knight will host ... 10:00 a.m. Central Time. A webcast of the presentation and ... available via the Internet. This listen-only webcast can be accessed ... www.aon.com . The webcast will be archived ...
... going forward, experts say , , MONDAY, May 11 (HealthDay News) ... and is likely to be comparable to other 20th century ... expert analysis concludes. , The analysis also suggests that the ... in Mexico, the outbreak,s epicenter, may have already reached 32,000 ...
... Health Week, National Osteoporosis Awareness and Prevention Month and National Arthritis ... with others nationwide , ... Minneapolis, Minnesota (PRWEB) May ... women. In addition to celebrating Mother,s Day, women across the country ...
... 16% to 20% in fiscal 2009SCOTTSDALE, Ariz., May 11 ... an over-the-counter healthcare company that develops and markets Zicam(R) ... better(R)," today announced financial results for its fourth quarter ... the fiscal year ended March 31, 2009, net sales ...
... Study suggests MRI scans better than questionnaires for evaluations ... seniors who,ve had a stroke fail to report that ... scans rather than patient self-reporting to determine stroke history. ... years and older (average age 80.1) in Manhattan. They ...
Cached Medicine News:Health News:Healthcare Realty Trust Announces First Quarter Results 2Health News:Healthcare Realty Trust Announces First Quarter Results 3Health News:Healthcare Realty Trust Announces First Quarter Results 4Health News:Healthcare Realty Trust Announces First Quarter Results 5Health News:Healthcare Realty Trust Announces First Quarter Results 6Health News:Healthcare Realty Trust Announces First Quarter Results 7Health News:Healthcare Realty Trust Announces First Quarter Results 8Health News:Healthcare Realty Trust Announces First Quarter Results 9Health News:Aon to Webcast Annual Shareholders' Meeting 2Health News:Study Supports Swine Flu's Pandemic Potential 2Health News:Study Supports Swine Flu's Pandemic Potential 3Health News:Study Supports Swine Flu's Pandemic Potential 4Health News:The Healthcare Scoop Seeks Women's Health, Osteoporosis, Arthritis Stories 2Health News:The Healthcare Scoop Seeks Women's Health, Osteoporosis, Arthritis Stories 3Health News:The Healthcare Scoop Seeks Women's Health, Osteoporosis, Arthritis Stories 4Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 2Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 3Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 4Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 5Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 6Health News:Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46 7Health News:Seniors Often Misstate Stroke History 2
... Zeiss was to find innovative solutions ... for preoperative computation of intraocular lenses ... work is the IOLMaster - a ... and setting a new standard for ...
Ahmed Glaucoma Valve with Pars Plana Clip....
... Long-term biocompatibility is established. Provides a robust ... ensure correct positioning on the globe. Pressure ... which, when covered by Tenons tissue, acts ... postoperative hypotony. The range of implants allows ...
... a low implant profile, 0.84mm, for better ... insertion is technically simpler and allows a ... installed with less trauma than multiple quadrant ... implant were designed to minimize bleb height ...
Medicine Products: